J. Macey

发表

Lung morphology assessment by using PETRA sequence at 1.5 Tesla: initial experience in patients

F. Laurent, M. Montaudon, O. Corneloup, 2015 .

Quantification of MRI T2 Interstitial Lung Disease Signal‐Intensity Volume in Idiopathic Pulmonary Fibrosis: A Pilot Study

F. Laurent, P. Berger, T. Benkert, 2020, Journal of magnetic resonance imaging : JMRI.

Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.

L. Meijer, S. Leroy, S. Hillion, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

3D ultrashort echo time MRI of the lung using stack‐of‐spirals and spherical k‐Space coverages: Evaluation in healthy volunteers and parenchymal diseases

F. Laurent, P. Berger, É. Blanchard, 2018, Journal of magnetic resonance imaging : JMRI.

Volumetric quantification of lung MR signal intensities using ultrashort TE as an automated score in cystic fibrosis

F. Laurent, P. Berger, C. Raherison, 2020, European Radiology.

[MRI of the pulmonary parenchyma: Towards clinical applicability?]

F. Laurent, P. Berger, É. Blanchard, 2017, Revue de pneumologie clinique.

Phase II Study of Interferon-enhanced 31 I-Labeled High Affinity CC 49 Monoclonal Antibody Therapy in Patients with Metastatic Prostate Cancer

J. Macey, E. Grizzle, 2007 .

Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

P. Reix, P. Burgel, C. Marguet, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo

P. Burgel, G. Thévenot, I. Fajac, 2011, European Respiratory Journal.

Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution

Michel Montaudon, Julie Macey, François Laurent, 2016, European Radiology.

Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients

M. Crouzet, C. Barthe, S. Vilain, 2015, Letters in applied microbiology.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease.

S. Leroy, P. Burgel, D. Grenet, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis.

F. Laurent, P. Berger, L. Delhaes, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

F. Laurent, M. Montaudon, P. Berger, 2015, Radiology.

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.

P. Burgel, J. Paillasseur, I. Durieu, 2021, American journal of respiratory and critical care medicine.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant

P. Burgel, I. Durieu, I. Sermet-Gaudelus, 2023, European Respiratory Journal.

The Clinical Use of Lung MRI in Cystic Fibrosis

F. Laurent, J. Woods, L. Walkup, 2020, Chest.

Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis

R. Enaud, M. Fayon, S. Bui, 2023, Frontiers in Pediatrics.

Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study

J. Mainz, S. Bell, M. Fridman, 2019, BMC Pulmonary Medicine.

Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study

H. Guet-Revillet, C. Segonds, S. Bui, 2020, BMC Pulmonary Medicine.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

David Grodzki, Michel Montaudon, Julie Macey, 2015, Radiology.

Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.

N. Rouas-Freiss, E. Carosella, M. Reynaud‐Gaubert, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

of the l ung is Feasible with a PeTra s equence at 1.5 T 1

F. Laurent, M. Montaudon, P. Berger, 2015 .

Quantification of MRI T2-weighted High Signal Volume in Cystic Fibrosis: A Pilot Study.

F. Laurent, P. Berger, S. Bui, 2019, Radiology.

Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.

F. Laurent, P. Berger, C. Dromer, 2019, Radiology.

Incidence, outcomes and risk factors for neoplasms in explanted lungs

J. Jougon, C. Dromer, H. Bégueret, 2016 .

Limited Stage Small Cell Lung Cancer: Analysis of Clinical Prognostic Factors

Robert V Farese, J. Hainsworth, W. Vaughn, 1987, Southern medical journal.

Management of initial colonisations with Burkholderia species in France, a retrospective analysis in five Cystic Fibrosis Centres

H. Guet-Revillet, C. Segonds, S. Bui, 2019 .

Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies.

C. Deligny, E. Lazaro, J. Viallard, 2023, European journal of internal medicine.

Non-contrast-Enhanced Functional Lung MRI to evaluate treatment response of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a pilot study

F. Laurent, J. Dinkel, B. D. Senneville, 2023, medRxiv.

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis.

F. Laurent, M. Montaudon, O. Corneloup, 2017, Radiology.

Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system

V. Cottin, R. Borie, M. Reynaud‐Gaubert, 2023, ERJ open research.

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease.

S. Leroy, P. Burgel, D. Grenet, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Longitudinal Evaluation of Bronchial Changes in Cystic Fibrosis Patients Undergoing Elexacaftor/Tezacaftor/Ivacaftor Therapy Using Lung MRI With Ultrashort Echo-Times.

G. Dournes, J. Macey, I. Benlala, 2023, Journal of magnetic resonance imaging : JMRI.

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis.

F. Laurent, P. Berger, L. Delhaes, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators

F. Laurent, P. Berger, B. Denis de Senneville, 2021, European Respiratory Journal.